Mr. Hood is a Managing Director and the Founding Partner of William Hood & Company, a differentiated industry-focused investment bank covering the Consumer, Food and Retail sectors.
Mr. Hood is well-known globally as a leading investment banker to the Consumer Products and Health & Wellness industries having led or been involved in many of the larger transactions including the sale of OLLY to Unilever, the sale of GNC’s Nutra subsidiary to IVC, the sale of Atrium (Garden of Life) to Nestlé for $2.4 billion, the sale of The Nature’s Bounty Company from The Carlyle Group to KKR, the sale of U.K.-based Holland & Barrett to Letter1 Retail for $2.3 billion, the sale of Unipharm to Takeda, the sale of Iovate to Xiwang for $850 million, the sale of Jamieson to CCMP, the sale of Santa Cruz to RoundTable, the sale of Schiff to Reckitt Benckiser for $1.4 billion, the sale of Avid Health (Lil’ Critters and Vitafusion) to Church & Dwight for $650 million, the purchase of Airborne by Schiff Nutrition and the sale of Emergen-C to Pfizer for $350 million among others.
Prior to launching William Hood & Company, Mr. Hood spent eight years as a Managing Director at Houlihan Lokey (HL) where he built and led the firm’s Consumer Health and Wellness practice. Mr. Hood began his career 22 years ago at PaineWebber Investment Banking in New York.
Widely regarded as an expert in the industry, Mr. Hood is frequently invited to speak about M&A at key Health and Wellness conferences including Expo West, the Nutrition Business Journal Summit, Supply Side West and ACG. Mr. Hood is also a contributor to industry and financial publications including the Wall Street Journal, Bloomberg News, Nutrition Business Journal, Whole Foods Magazine and the Daily Deal.
Mr. Hood has a global network and travels frequently to Europe and Asia. He grew up in the U.K. and Hong Kong and holds a B.S. from Georgetown University.
Mr. Hood serves on the Board of Advisors for Vitamin Angels.